Kraws Jeffrey J 4
4 · Synthetic Biologics, Inc. · Filed Dec 7, 2018
Insider Transaction Report
Form 4
Kraws Jeffrey J
Director
Transactions
- Award
Stock Options
2018-12-06+79,500→ 79,500 totalExercise: $0.69From: 2018-12-06Exp: 2025-12-06→ Common Stock (79,500 underlying)
Footnotes (1)
- [F1]These options will vest monthly on a pro rata basis over 36 consecutive months.